1-(tert-butyl) 3-methyl azepane-1,3-dicarboxylate

Catalog No.: 
ACTOLX410
CAS No.: 
2110548-40-6
Molecular Formula: 
C13H23NO4
Molecular Weight: 
257.33
1-(tert-butyl) 3-methyl azepane-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$193.00In stockInquiry
250mg97%$322.00In stockInquiry
500mg97%$453.00In stockInquiry
1g97%$647.00In stockInquiry
5g97%$1941.00In stockInquiry
10g97%$3235.00In stockInquiry
25g97%$7117.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-butyl) 3-methyl azepane-1,3-dicarboxylate
IUPAC Name1-(tert-butyl) 3-methyl azepane-1,3-dicarboxylate
Molecular FormulaC13H23NO4
Molecular Weight257.33
SMILESCOC(=O)C1CCCCN(C(=O)OC(C)(C)C)C1
InChI KeyOJPSBHKVOGORGV-UHFFFAOYSA-N
Synonym1H-Azepine-1,3-dicarboxylic acid, hexahydro-, 1-(1,1-dimethylethyl) 3-methyl ester;O1-tert-butyl O3-methyl azepane-1,3-dicarboxylate;1-(tert-Butyl) 3-methyl azepane-1,3-dicarboxylate;O1-tert-butyl O3-methyl azepane-1,3-dicarboxylate - [B84789]
CAS No.2110548-40-6

Synthetic Route by SureRoute

1. ACTOLX410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTJKY072 route compound structure diagram
    ACTJKY072198959-48-7In Stock
  4. Then
  5. ACTOLX410 route product structure diagram
    ACTOLX4102110548-40-6In Stock
Inquiry

2. ACTOLX410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOLX410 route product structure diagram
    ACTOLX4102110548-40-6In Stock
Inquiry

3. ACTOLX410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOLX410 route product structure diagram
    ACTOLX4102110548-40-6In Stock
Inquiry

Comments (0)